世界のアシクロビル治療薬市場予測 2023年-2029年

【英語タイトル】Global Aciclovir Drug Market Growth 2023-2029

LP Informationが出版した調査資料(LP23DC03641)・商品コード:LP23DC03641
・発行会社(調査会社):LP Information
・発行日:2023年11月
・ページ数:108
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品&医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥556,320見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥834,480見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,112,640見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のアシクロビル治療薬市場」は、過去の販売実績から2022年の世界のアシクロビル治療薬の総販売量を検討し、2023年から2029年の予測されるアシクロビル治療薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のアシクロビル治療薬の市場規模を掲載し、XXX百万米ドル規模の世界のアシクロビル治療薬市場の詳細な分析を提供します。本インサイトレポートは、世界のアシクロビル治療薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のアシクロビル治療薬市場における各社の独自のポジションをより深く理解するために、アシクロビル治療薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のアシクロビル治療薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。アシクロビル治療薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000%と予測されています。アシクロビル治療薬の中国市場は、2023年から2029年までの年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。アシクロビル治療薬のヨーロッパ市場は、2023年から2029年にかけて年平均000%成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

アシクロビル治療薬の世界主要メーカーとしては、RelonChem、 Cipla、 Vectans Pharma、 Fresenius Kabi、 Blue Pharma、 Zydus Pharmaceuticals、 Novus Life Sciences、 Talent Healthcare、 Actiza Pharma、 UNITED LABORATOR IES、 SHANGHAI CP GENERAL PHARMACEUTICAL、 Yiling Pharmaceutical、 Kangzheng Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000%のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のアシクロビル治療薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではアシクロビル治療薬市場をセグメンテーションし、種類別 (経口錠剤、点滴静注用製剤、軟膏外用剤)、用途別 (単純ヘルペスウイルス感染症、帯状疱疹、免疫不全者の水痘、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分:経口錠剤、点滴静注用製剤、軟膏外用剤

・用途別区分:単純ヘルペスウイルス感染症、帯状疱疹、免疫不全者の水痘、その他

・地域別区分
南北アメリカ(アメリカ、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
ヨーロッパ(ドイツ、フランス、イギリス、イタリア、ロシア)
中東・アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

【本レポートで扱う主な質問】

・世界のアシクロビル治療薬市場の10年間の市場状況・展望は?
・世界および地域別に見たアシクロビル治療薬市場成長の要因は何か?
・アシクロビル治療薬の市場機会はエンドマーケットの規模によってどのように変化するのか?
・アシクロビル治療薬のタイプ別、用途別の内訳は?
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は?

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:アシクロビル治療薬の年間販売量2018-2029、地域別現状・将来分析
・アシクロビル治療薬の種類別セグメント:経口錠剤、点滴静注用製剤、軟膏外用剤
・アシクロビル治療薬の種類別販売量:2018-2023年の販売量、売上、市場シェア、販売価格
・アシクロビル治療薬の用途別セグメント:単純ヘルペスウイルス感染症、帯状疱疹、免疫不全者の水痘、その他
・アシクロビル治療薬の用途別販売量:2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のアシクロビル治療薬市場
・企業別のグローバルアシクロビル治療薬市場データ:2018-2023年の年間販売量、市場シェア
・企業別のアシクロビル治療薬の年間売上:2018-2023年の売上、市場シェア
・企業別のアシクロビル治療薬販売価格
・主要企業のアシクロビル治療薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

アシクロビル治療薬の地域別レビュー
・地域別のアシクロビル治療薬市場規模2018-2023:年間販売量、売上
・主要国別のアシクロビル治療薬市場規模2018-2023:年間販売量、売上
・南北アメリカのアシクロビル治療薬販売の成長
・アジア太平洋のアシクロビル治療薬販売の成長
・ヨーロッパのアシクロビル治療薬販売の成長
・中東・アフリカのアシクロビル治療薬販売の成長

南北アメリカ市場
・南北アメリカの国別のアシクロビル治療薬販売量、売上(2018-2023)
・南北アメリカのアシクロビル治療薬の種類別販売量
・南北アメリカのアシクロビル治療薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のアシクロビル治療薬販売量、売上(2018-2023)
・アジア太平洋のアシクロビル治療薬の種類別販売量
・アジア太平洋のアシクロビル治療薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のアシクロビル治療薬販売量、売上(2018-2023)
・ヨーロッパのアシクロビル治療薬の種類別販売量
・ヨーロッパのアシクロビル治療薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のアシクロビル治療薬販売量、売上(2018-2023)
・中東・アフリカのアシクロビル治療薬の種類別販売量
・中東・アフリカのアシクロビル治療薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・アシクロビル治療薬の製造コスト構造分析
・アシクロビル治療薬の製造プロセス分析
・アシクロビル治療薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・アシクロビル治療薬の主要なグローバル販売業者
・アシクロビル治療薬の主要なグローバル顧客

地域別のアシクロビル治療薬市場予測レビュー
・地域別のアシクロビル治療薬市場規模予測(2024-2029)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・アシクロビル治療薬の種類別市場規模予測
・アシクロビル治療薬の用途別市場規模予測

主要企業分析
RelonChem、 Cipla、 Vectans Pharma、 Fresenius Kabi、 Blue Pharma、 Zydus Pharmaceuticals、 Novus Life Sciences、 Talent Healthcare、 Actiza Pharma、 UNITED LABORATOR IES、 SHANGHAI CP GENERAL PHARMACEUTICAL、 Yiling Pharmaceutical、 Kangzheng Pharmaceutical
・企業情報
・アシクロビル治療薬製品
・アシクロビル治療薬販売量、売上、価格、粗利益(2018-2023)
・主要ビジネス概要
・最新動向

調査結果および結論

The global Aciclovir Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Aciclovir Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Aciclovir Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Aciclovir Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Aciclovir Drug players cover RelonChem, Cipla, Vectans Pharma, Fresenius Kabi, Blue Pharma, Zydus Pharmaceuticals, Novus Life Sciences, Talent Healthcare and Actiza Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The acyclovir drug is a guanine analogue antiviral drug.
LPI (LP Information)’ newest research report, the “Aciclovir Drug Industry Forecast” looks at past sales and reviews total world Aciclovir Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Aciclovir Drug sales for 2023 through 2029. With Aciclovir Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aciclovir Drug industry.
This Insight Report provides a comprehensive analysis of the global Aciclovir Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aciclovir Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Aciclovir Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aciclovir Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aciclovir Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Aciclovir Drug market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Oral Tablet
Lntravenous Dosage Forms
Topical Ointment
Segmentation by application
Herpes Simplex Virus Infection
Shingles
Chickenpox in Immunocompromised Persons
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
RelonChem
Cipla
Vectans Pharma
Fresenius Kabi
Blue Pharma
Zydus Pharmaceuticals
Novus Life Sciences
Talent Healthcare
Actiza Pharma
UNITED LABORATOR IES
SHANGHAI CP GENERAL PHARMACEUTICAL
Yiling Pharmaceutical
Kangzheng Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aciclovir Drug market?
What factors are driving Aciclovir Drug market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aciclovir Drug market opportunities vary by end market size?
How does Aciclovir Drug break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Aciclovir Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Aciclovir Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Aciclovir Drug by Country/Region, 2018, 2022 & 2029
2.2 Aciclovir Drug Segment by Type
2.2.1 Oral Tablet
2.2.2 Lntravenous Dosage Forms
2.2.3 Topical Ointment
2.3 Aciclovir Drug Sales by Type
2.3.1 Global Aciclovir Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Aciclovir Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Aciclovir Drug Sale Price by Type (2018-2023)
2.4 Aciclovir Drug Segment by Application
2.4.1 Herpes Simplex Virus Infection
2.4.2 Shingles
2.4.3 Chickenpox in Immunocompromised Persons
2.4.4 Others
2.5 Aciclovir Drug Sales by Application
2.5.1 Global Aciclovir Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Aciclovir Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Aciclovir Drug Sale Price by Application (2018-2023)
3 Global Aciclovir Drug by Company
3.1 Global Aciclovir Drug Breakdown Data by Company
3.1.1 Global Aciclovir Drug Annual Sales by Company (2018-2023)
3.1.2 Global Aciclovir Drug Sales Market Share by Company (2018-2023)
3.2 Global Aciclovir Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Aciclovir Drug Revenue by Company (2018-2023)
3.2.2 Global Aciclovir Drug Revenue Market Share by Company (2018-2023)
3.3 Global Aciclovir Drug Sale Price by Company
3.4 Key Manufacturers Aciclovir Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aciclovir Drug Product Location Distribution
3.4.2 Players Aciclovir Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Aciclovir Drug by Geographic Region
4.1 World Historic Aciclovir Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Aciclovir Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Aciclovir Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Aciclovir Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Aciclovir Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Aciclovir Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Aciclovir Drug Sales Growth
4.4 APAC Aciclovir Drug Sales Growth
4.5 Europe Aciclovir Drug Sales Growth
4.6 Middle East & Africa Aciclovir Drug Sales Growth
5 Americas
5.1 Americas Aciclovir Drug Sales by Country
5.1.1 Americas Aciclovir Drug Sales by Country (2018-2023)
5.1.2 Americas Aciclovir Drug Revenue by Country (2018-2023)
5.2 Americas Aciclovir Drug Sales by Type
5.3 Americas Aciclovir Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aciclovir Drug Sales by Region
6.1.1 APAC Aciclovir Drug Sales by Region (2018-2023)
6.1.2 APAC Aciclovir Drug Revenue by Region (2018-2023)
6.2 APAC Aciclovir Drug Sales by Type
6.3 APAC Aciclovir Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aciclovir Drug by Country
7.1.1 Europe Aciclovir Drug Sales by Country (2018-2023)
7.1.2 Europe Aciclovir Drug Revenue by Country (2018-2023)
7.2 Europe Aciclovir Drug Sales by Type
7.3 Europe Aciclovir Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aciclovir Drug by Country
8.1.1 Middle East & Africa Aciclovir Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Aciclovir Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Aciclovir Drug Sales by Type
8.3 Middle East & Africa Aciclovir Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aciclovir Drug
10.3 Manufacturing Process Analysis of Aciclovir Drug
10.4 Industry Chain Structure of Aciclovir Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aciclovir Drug Distributors
11.3 Aciclovir Drug Customer
12 World Forecast Review for Aciclovir Drug by Geographic Region
12.1 Global Aciclovir Drug Market Size Forecast by Region
12.1.1 Global Aciclovir Drug Forecast by Region (2024-2029)
12.1.2 Global Aciclovir Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Aciclovir Drug Forecast by Type
12.7 Global Aciclovir Drug Forecast by Application
13 Key Players Analysis
13.1 RelonChem
13.1.1 RelonChem Company Information
13.1.2 RelonChem Aciclovir Drug Product Portfolios and Specifications
13.1.3 RelonChem Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 RelonChem Main Business Overview
13.1.5 RelonChem Latest Developments
13.2 Cipla
13.2.1 Cipla Company Information
13.2.2 Cipla Aciclovir Drug Product Portfolios and Specifications
13.2.3 Cipla Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cipla Main Business Overview
13.2.5 Cipla Latest Developments
13.3 Vectans Pharma
13.3.1 Vectans Pharma Company Information
13.3.2 Vectans Pharma Aciclovir Drug Product Portfolios and Specifications
13.3.3 Vectans Pharma Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Vectans Pharma Main Business Overview
13.3.5 Vectans Pharma Latest Developments
13.4 Fresenius Kabi
13.4.1 Fresenius Kabi Company Information
13.4.2 Fresenius Kabi Aciclovir Drug Product Portfolios and Specifications
13.4.3 Fresenius Kabi Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fresenius Kabi Main Business Overview
13.4.5 Fresenius Kabi Latest Developments
13.5 Blue Pharma
13.5.1 Blue Pharma Company Information
13.5.2 Blue Pharma Aciclovir Drug Product Portfolios and Specifications
13.5.3 Blue Pharma Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Blue Pharma Main Business Overview
13.5.5 Blue Pharma Latest Developments
13.6 Zydus Pharmaceuticals
13.6.1 Zydus Pharmaceuticals Company Information
13.6.2 Zydus Pharmaceuticals Aciclovir Drug Product Portfolios and Specifications
13.6.3 Zydus Pharmaceuticals Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zydus Pharmaceuticals Main Business Overview
13.6.5 Zydus Pharmaceuticals Latest Developments
13.7 Novus Life Sciences
13.7.1 Novus Life Sciences Company Information
13.7.2 Novus Life Sciences Aciclovir Drug Product Portfolios and Specifications
13.7.3 Novus Life Sciences Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Novus Life Sciences Main Business Overview
13.7.5 Novus Life Sciences Latest Developments
13.8 Talent Healthcare
13.8.1 Talent Healthcare Company Information
13.8.2 Talent Healthcare Aciclovir Drug Product Portfolios and Specifications
13.8.3 Talent Healthcare Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Talent Healthcare Main Business Overview
13.8.5 Talent Healthcare Latest Developments
13.9 Actiza Pharma
13.9.1 Actiza Pharma Company Information
13.9.2 Actiza Pharma Aciclovir Drug Product Portfolios and Specifications
13.9.3 Actiza Pharma Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Actiza Pharma Main Business Overview
13.9.5 Actiza Pharma Latest Developments
13.10 UNITED LABORATOR IES
13.10.1 UNITED LABORATOR IES Company Information
13.10.2 UNITED LABORATOR IES Aciclovir Drug Product Portfolios and Specifications
13.10.3 UNITED LABORATOR IES Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 UNITED LABORATOR IES Main Business Overview
13.10.5 UNITED LABORATOR IES Latest Developments
13.11 SHANGHAI CP GENERAL PHARMACEUTICAL
13.11.1 SHANGHAI CP GENERAL PHARMACEUTICAL Company Information
13.11.2 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Product Portfolios and Specifications
13.11.3 SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SHANGHAI CP GENERAL PHARMACEUTICAL Main Business Overview
13.11.5 SHANGHAI CP GENERAL PHARMACEUTICAL Latest Developments
13.12 Yiling Pharmaceutical
13.12.1 Yiling Pharmaceutical Company Information
13.12.2 Yiling Pharmaceutical Aciclovir Drug Product Portfolios and Specifications
13.12.3 Yiling Pharmaceutical Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Yiling Pharmaceutical Main Business Overview
13.12.5 Yiling Pharmaceutical Latest Developments
13.13 Kangzheng Pharmaceutical
13.13.1 Kangzheng Pharmaceutical Company Information
13.13.2 Kangzheng Pharmaceutical Aciclovir Drug Product Portfolios and Specifications
13.13.3 Kangzheng Pharmaceutical Aciclovir Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Kangzheng Pharmaceutical Main Business Overview
13.13.5 Kangzheng Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Aciclovir Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Aciclovir Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral Tablet
Table 4. Major Players of Lntravenous Dosage Forms
Table 5. Major Players of Topical Ointment
Table 6. Global Aciclovir Drug Sales by Type (2018-2023) & (K Units)
Table 7. Global Aciclovir Drug Sales Market Share by Type (2018-2023)
Table 8. Global Aciclovir Drug Revenue by Type (2018-2023) & ($ million)
Table 9. Global Aciclovir Drug Revenue Market Share by Type (2018-2023)
Table 10. Global Aciclovir Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Aciclovir Drug Sales by Application (2018-2023) & (K Units)
Table 12. Global Aciclovir Drug Sales Market Share by Application (2018-2023)
Table 13. Global Aciclovir Drug Revenue by Application (2018-2023)
Table 14. Global Aciclovir Drug Revenue Market Share by Application (2018-2023)
Table 15. Global Aciclovir Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Aciclovir Drug Sales by Company (2018-2023) & (K Units)
Table 17. Global Aciclovir Drug Sales Market Share by Company (2018-2023)
Table 18. Global Aciclovir Drug Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Aciclovir Drug Revenue Market Share by Company (2018-2023)
Table 20. Global Aciclovir Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Aciclovir Drug Producing Area Distribution and Sales Area
Table 22. Players Aciclovir Drug Products Offered
Table 23. Aciclovir Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Aciclovir Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Aciclovir Drug Sales Market Share Geographic Region (2018-2023)
Table 28. Global Aciclovir Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Aciclovir Drug Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Aciclovir Drug Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Aciclovir Drug Sales Market Share by Country/Region (2018-2023)
Table 32. Global Aciclovir Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Aciclovir Drug Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Aciclovir Drug Sales by Country (2018-2023) & (K Units)
Table 35. Americas Aciclovir Drug Sales Market Share by Country (2018-2023)
Table 36. Americas Aciclovir Drug Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Aciclovir Drug Revenue Market Share by Country (2018-2023)
Table 38. Americas Aciclovir Drug Sales by Type (2018-2023) & (K Units)
Table 39. Americas Aciclovir Drug Sales by Application (2018-2023) & (K Units)
Table 40. APAC Aciclovir Drug Sales by Region (2018-2023) & (K Units)
Table 41. APAC Aciclovir Drug Sales Market Share by Region (2018-2023)
Table 42. APAC Aciclovir Drug Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Aciclovir Drug Revenue Market Share by Region (2018-2023)
Table 44. APAC Aciclovir Drug Sales by Type (2018-2023) & (K Units)
Table 45. APAC Aciclovir Drug Sales by Application (2018-2023) & (K Units)
Table 46. Europe Aciclovir Drug Sales by Country (2018-2023) & (K Units)
Table 47. Europe Aciclovir Drug Sales Market Share by Country (2018-2023)
Table 48. Europe Aciclovir Drug Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Aciclovir Drug Revenue Market Share by Country (2018-2023)
Table 50. Europe Aciclovir Drug Sales by Type (2018-2023) & (K Units)
Table 51. Europe Aciclovir Drug Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Aciclovir Drug Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Aciclovir Drug Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Aciclovir Drug Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Aciclovir Drug Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Aciclovir Drug Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Aciclovir Drug Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Aciclovir Drug
Table 59. Key Market Challenges & Risks of Aciclovir Drug
Table 60. Key Industry Trends of Aciclovir Drug
Table 61. Aciclovir Drug Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Aciclovir Drug Distributors List
Table 64. Aciclovir Drug Customer List
Table 65. Global Aciclovir Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Aciclovir Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Aciclovir Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Aciclovir Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Aciclovir Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Aciclovir Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Aciclovir Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Aciclovir Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Aciclovir Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Aciclovir Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Aciclovir Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Aciclovir Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Aciclovir Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Aciclovir Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. RelonChem Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. RelonChem Aciclovir Drug Product Portfolios and Specifications
Table 81. RelonChem Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. RelonChem Main Business
Table 83. RelonChem Latest Developments
Table 84. Cipla Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Cipla Aciclovir Drug Product Portfolios and Specifications
Table 86. Cipla Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Cipla Main Business
Table 88. Cipla Latest Developments
Table 89. Vectans Pharma Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. Vectans Pharma Aciclovir Drug Product Portfolios and Specifications
Table 91. Vectans Pharma Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Vectans Pharma Main Business
Table 93. Vectans Pharma Latest Developments
Table 94. Fresenius Kabi Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Fresenius Kabi Aciclovir Drug Product Portfolios and Specifications
Table 96. Fresenius Kabi Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Fresenius Kabi Main Business
Table 98. Fresenius Kabi Latest Developments
Table 99. Blue Pharma Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Blue Pharma Aciclovir Drug Product Portfolios and Specifications
Table 101. Blue Pharma Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Blue Pharma Main Business
Table 103. Blue Pharma Latest Developments
Table 104. Zydus Pharmaceuticals Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Zydus Pharmaceuticals Aciclovir Drug Product Portfolios and Specifications
Table 106. Zydus Pharmaceuticals Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Zydus Pharmaceuticals Main Business
Table 108. Zydus Pharmaceuticals Latest Developments
Table 109. Novus Life Sciences Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Novus Life Sciences Aciclovir Drug Product Portfolios and Specifications
Table 111. Novus Life Sciences Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Novus Life Sciences Main Business
Table 113. Novus Life Sciences Latest Developments
Table 114. Talent Healthcare Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Talent Healthcare Aciclovir Drug Product Portfolios and Specifications
Table 116. Talent Healthcare Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Talent Healthcare Main Business
Table 118. Talent Healthcare Latest Developments
Table 119. Actiza Pharma Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Actiza Pharma Aciclovir Drug Product Portfolios and Specifications
Table 121. Actiza Pharma Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Actiza Pharma Main Business
Table 123. Actiza Pharma Latest Developments
Table 124. UNITED LABORATOR IES Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. UNITED LABORATOR IES Aciclovir Drug Product Portfolios and Specifications
Table 126. UNITED LABORATOR IES Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. UNITED LABORATOR IES Main Business
Table 128. UNITED LABORATOR IES Latest Developments
Table 129. SHANGHAI CP GENERAL PHARMACEUTICAL Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Product Portfolios and Specifications
Table 131. SHANGHAI CP GENERAL PHARMACEUTICAL Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. SHANGHAI CP GENERAL PHARMACEUTICAL Main Business
Table 133. SHANGHAI CP GENERAL PHARMACEUTICAL Latest Developments
Table 134. Yiling Pharmaceutical Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 135. Yiling Pharmaceutical Aciclovir Drug Product Portfolios and Specifications
Table 136. Yiling Pharmaceutical Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Yiling Pharmaceutical Main Business
Table 138. Yiling Pharmaceutical Latest Developments
Table 139. Kangzheng Pharmaceutical Basic Information, Aciclovir Drug Manufacturing Base, Sales Area and Its Competitors
Table 140. Kangzheng Pharmaceutical Aciclovir Drug Product Portfolios and Specifications
Table 141. Kangzheng Pharmaceutical Aciclovir Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Kangzheng Pharmaceutical Main Business
Table 143. Kangzheng Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Aciclovir Drug
Figure 2. Aciclovir Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Aciclovir Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Aciclovir Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Aciclovir Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral Tablet
Figure 10. Product Picture of Lntravenous Dosage Forms
Figure 11. Product Picture of Topical Ointment
Figure 12. Global Aciclovir Drug Sales Market Share by Type in 2022
Figure 13. Global Aciclovir Drug Revenue Market Share by Type (2018-2023)
Figure 14. Aciclovir Drug Consumed in Herpes Simplex Virus Infection
Figure 15. Global Aciclovir Drug Market: Herpes Simplex Virus Infection (2018-2023) & (K Units)
Figure 16. Aciclovir Drug Consumed in Shingles
Figure 17. Global Aciclovir Drug Market: Shingles (2018-2023) & (K Units)
Figure 18. Aciclovir Drug Consumed in Chickenpox in Immunocompromised Persons
Figure 19. Global Aciclovir Drug Market: Chickenpox in Immunocompromised Persons (2018-2023) & (K Units)
Figure 20. Aciclovir Drug Consumed in Others
Figure 21. Global Aciclovir Drug Market: Others (2018-2023) & (K Units)
Figure 22. Global Aciclovir Drug Sales Market Share by Application (2022)
Figure 23. Global Aciclovir Drug Revenue Market Share by Application in 2022
Figure 24. Aciclovir Drug Sales Market by Company in 2022 (K Units)
Figure 25. Global Aciclovir Drug Sales Market Share by Company in 2022
Figure 26. Aciclovir Drug Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Aciclovir Drug Revenue Market Share by Company in 2022
Figure 28. Global Aciclovir Drug Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Aciclovir Drug Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Aciclovir Drug Sales 2018-2023 (K Units)
Figure 31. Americas Aciclovir Drug Revenue 2018-2023 ($ Millions)
Figure 32. APAC Aciclovir Drug Sales 2018-2023 (K Units)
Figure 33. APAC Aciclovir Drug Revenue 2018-2023 ($ Millions)
Figure 34. Europe Aciclovir Drug Sales 2018-2023 (K Units)
Figure 35. Europe Aciclovir Drug Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Aciclovir Drug Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Aciclovir Drug Revenue 2018-2023 ($ Millions)
Figure 38. Americas Aciclovir Drug Sales Market Share by Country in 2022
Figure 39. Americas Aciclovir Drug Revenue Market Share by Country in 2022
Figure 40. Americas Aciclovir Drug Sales Market Share by Type (2018-2023)
Figure 41. Americas Aciclovir Drug Sales Market Share by Application (2018-2023)
Figure 42. United States Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Aciclovir Drug Sales Market Share by Region in 2022
Figure 47. APAC Aciclovir Drug Revenue Market Share by Regions in 2022
Figure 48. APAC Aciclovir Drug Sales Market Share by Type (2018-2023)
Figure 49. APAC Aciclovir Drug Sales Market Share by Application (2018-2023)
Figure 50. China Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Aciclovir Drug Sales Market Share by Country in 2022
Figure 58. Europe Aciclovir Drug Revenue Market Share by Country in 2022
Figure 59. Europe Aciclovir Drug Sales Market Share by Type (2018-2023)
Figure 60. Europe Aciclovir Drug Sales Market Share by Application (2018-2023)
Figure 61. Germany Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Aciclovir Drug Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Aciclovir Drug Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Aciclovir Drug Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Aciclovir Drug Sales Market Share by Application (2018-2023)
Figure 70. Egypt Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Aciclovir Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Aciclovir Drug in 2022
Figure 76. Manufacturing Process Analysis of Aciclovir Drug
Figure 77. Industry Chain Structure of Aciclovir Drug
Figure 78. Channels of Distribution
Figure 79. Global Aciclovir Drug Sales Market Forecast by Region (2024-2029)
Figure 80. Global Aciclovir Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Aciclovir Drug Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Aciclovir Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Aciclovir Drug Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Aciclovir Drug Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のアシクロビル治療薬市場予測 2023年-2029年] (コード:LP23DC03641)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のアシクロビル治療薬市場予測 2023年-2029年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆